IFP Advisors
AMRX icon

IFP Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

IFP Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.9K Hold
689
– – ﹤0.01% 3180
2026
Q2 		$11.9K Sell
689
-148
-18% -$2.03K ﹤0.01% 3279
2026
Q1 		$10.4K Buy
837
+148
+21% +$1.99K ﹤0.01% 3132
2025
Q4 		$8.68K Buy
689
+21
+3% +$240 ﹤0.01% 3134
2025
Q3 		$6.69K Sell
668
-26
-4% -$233 ﹤0.01% 3100
2025
Q2 		$5.62K Buy
+694
New +$5.23K ﹤0.01% 3292
2025
Q1 		– Hold
0
– – – 3936
2024
Q4 		– Hold
0
– – – 4143
2023
Q1 		– Sell
-99,211
Closed -$1.97M – 3390
2022
Q4 		$1.97M Buy
99,211
+3,058
+3% +$6.86K 0.05% 373
2022
Q3 		$1.91M Buy
96,153
+94,378
+5,317% +$264K 0.05% 421
2022
Q2 		$35K Hold
1,775
– – ﹤0.01% 2406
2022
Q1 		$35K Buy
1,775
+1,250
+238% +$5.54K ﹤0.01% 2406
2021
Q4 		$3K Hold
525
– – ﹤0.01% 2637
2021
Q3 		$3K Buy
525
+150
+40% +$755 ﹤0.01% 2694
2021
Q2 		$2K Hold
375
– – ﹤0.01% 2709
2021
Q1 		$3K Buy
+375
New +$2.08K ﹤0.01% 2535
2020
Q3 		– Sell
-2,000
Closed -$8.55K – 2838
2020
Q2 		$9K Buy
+2,000
New +$8.24K ﹤0.01% 1850
2018
Q4 		– Sell
-5,748
Closed -$128K – 3508
2018
Q3 		$128K Hold
5,748
– – 0.01% 1332
2018
Q2 		$94K Buy
+5,748
New +$101K ﹤0.01% 1517

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors's AMRX Position: Q3 2026 in Review

IFP Advisors held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 689 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

IFP Advisors first reported a position in AMRX in Q2 2018 and has held it in 17 quarters since. The position peaked at $1.97M in Q4 2022. 43 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • IFP Advisors held 689 shares of Amneal Pharmaceuticals worth $13.9K as of Q3 2026.
  • IFP Advisors left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3180 holding.
  • IFP Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 17 quarters since.
  • IFP Advisors's Amneal Pharmaceuticals position peaked at $1.97M in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.